Hepatitis C Virus Infection

Known as: HCV Infection 
An infection that is caused by hepatitis C virus.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.
Background Rapid improvements in hepatitis C virus (HCV) therapy have led to the approval of multiple oral direct-acting… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection.
Eight weeks duration of ledipasvir/sofosbuvir (LDV/SOF) can be considered in genotype 1 hepatitis C virus-infected patients who… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2017
Review
2017
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review
AIM To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning the prevalence of glucose… (More)
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2017
Review
2017
Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial.
Nearly 10% of kidney transplant recipients in Western countries have chronic hepatitis C virus (HCV) infection (1). The higher… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
2017
Review
2017
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.
BACKGROUND The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Global epidemiology and burden of HCV infection and HCV-related disease
Chronic HCV infection is a global health problem that affects >184 million people worldwide. HCV is associated with several… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2017
Review
2017
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event…
An estimated 170 million persons worldwide have hepatitis C virus (HCV) infection (1), including 2.7 million to 3.9 million in… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Telaprevir for previously untreated chronic hepatitis C virus infection.
BACKGROUND In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Review
2005
Review
2005
Global epidemiology of hepatitis C virus infection.
Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
BACKGROUND Treatment with peginterferon alfa-2a alone produces significantly higher sustained virologic responses than treatment… (More)
  • figure 1
  • figure 2
  • table 3
Is this relevant?